A prospective study of the sensitivity, specificity and diagnostic performance of soluble intercellular adhesion molecule 1, highly sensitive C-reactive protein, soluble E-selectin and serum amyloid A in the diagnosis of neonatal infection

J David M Edgar, Vanessa Gabriel, J Ruth Gallimore, Stanley A McMillan, Judith Grant, J David M Edgar, Vanessa Gabriel, J Ruth Gallimore, Stanley A McMillan, Judith Grant

Abstract

Background: Diagnosis of neonatal infection is difficult, because of it's non-specific clinical presentation and the lack of reliable diagnostic tests. The purpose of this study was to examine the potential diagnostic value of serum soluble intercellular adhesion molecule-1 (sICAM-1), soluble E-selectin (sE-selectin), highly sensitive C-reactive protein (hsCRP) and serum amyloid A (SAA) measurements, both individually and in combination in the setting of a neonatal intensive care unit.

Methods: 219 consecutive serum samples were taken from 149 infants undergoing sepsis work up in a neonatal intensive care unit. Clinical diagnosis was established in a prospective manner, blind to the results of the study measurements. Infants were classified by an experienced paediatrician as infected or not-infected, one week after presentation. Classification was based on clinical presentation, routine laboratory and radiological investigations and response to therapy. The infected group were sub-classified as (a) culture positive infection or (b) culture negative infection. sICAM-1, sE-selectin, hsCRP and SAA levels were determined from stored serum samples after diagnosis was established. Further sub-group analysis of results was undertaken according to early or late onset of infection and preterm or term status. Statistical analysis utilised Mann Whitney U test and ROC curve analysis.

Results: There were significantly increased serum levels of sICAM-1, hsCRP, E selectin (p < 0.001) and SAA (p = 0.004) in infected infants compared with non-infected. ROC curve analysis indicated area under the curve values of 0.79 (sICAM-1), 0.73 (hsCRP), 0.72 (sE-selectin) and 0.61 (SAA). ROC curve analysis also defined optimum diagnostic cut-off levels for each measurement. The performance characteristics of sICAM-1, hsCRP and sE-selectin included a high negative predictive value (NPV) for culture positive infection and this was enhanced by combination of all 4 measurements. Clinical subgroup analysis suggested particularly high NPV for early onset symptoms, however further studies are required to elucidate this finding.

Conclusions: All four study measurements demonstrated some diagnostic value for neonatal infection however sICAM-1, hsCRP and sE-selectin demonstrated the highest NPV individually. The optimum diagnostic cut off level for hsCRP measurement in this study was much lower than currently used in routine clinical practice. Use of a combination of measurements enhanced diagnostic performance, demonstrating sensitivity of 90.3% and NPV of 91.3%. This study suggests there may be value in use of several of these markers, individually and in combination to assist in excluding neonatal infection. Further work is needed to confirm a specific role in the exclusion of early onset infection.

Figures

Figure 1
Figure 1
Initial classification at enrolment to the study.
Figure 2
Figure 2
Classification of samples after one week.
Figure 3
Figure 3
Receiver operating characteristic (ROC) curve for all test measurements in the diagnosis of infection.
Figure 4
Figure 4
Receiver operating characteristic (ROC) curve for all test measurements in the diagnosis of culture positive infection.

References

    1. Ng PC. Diagnostic markers of infection in neonates. Arch Dis Child Fetal Neonatal Ed. 2004;89:F229–F235. doi: 10.1136/adc.2002.023838.
    1. Lam HS, Ng PC. Biochemical markers of neonatal sepsis. Pathology. 2008;40(2):141–8. doi: 10.1080/00313020701813735.
    1. Griffin MP, Lake DE, Bissonette EA, Harrell FE, O'Shea TM, Moorman JR. Heart rate characteristics: novel physiomarkers to predict neonatal infection and death. Pediatrics. 2005;116:1070–4. doi: 10.1542/peds.2004-2461.
    1. Edgar JDM, Wilson DC, McMillan SA, Crockard AD, Halliday MI, Rowlands BJ, Gardiner KRG, Halliday HL, McNeill TA. Predictive value of soluble immunological mediators in neonatal infection. Clin Sci. 1994;87:165–71.
    1. Wilson DC, Edgar JD. Predictors of bacterial infection in neonates. J Pediatr. 1997;129:166.
    1. Edgar JDM, Gabriel V, Craig A, Wheeler D, Thomas MJ, Grant J. A low serum sICAM-1 level may assist in the exclusion of neonatal infection. Biol Neonate. 2002;81(2):105–8. doi: 10.1159/000047193.
    1. Wasunna A, Whitelaw A, Gallimore R, Hawkins PN, Pepys MB. C-reactive protein and bacterial infection in preterm infants. Eur J Pediatr. 1990;149:424–7. doi: 10.1007/BF02009664.
    1. Austgulen R, Arntzen KJ, Haereid PE, Aag S, Dollner H. Infections in neonates delivered at term are associated with increased serum levels of ICAM-1 and E-selectin. Acta Paediatr. 1997;86(3):274–80. doi: 10.1111/j.1651-2227.1997.tb08889.x.
    1. Lannergård A, Larsson A, Friman G, Ewald U. Human serum amyloid A (SAA) and high sensitive C-reactive protein (hsCRP) in preterm newborn infants with nosocomial infections. Acta Pædiatr. 2008;97(8):1061–1065. doi: 10.1111/j.1651-2227.2008.00814.x.
    1. Ng PC. Clinical trials for evaluating diagnostic markers of infection in neonates. Biol Neonate. 2005;87:111–2. doi: 10.1159/000081980.
    1. Kingsmore SF, Kennedy N, Halliday HL, Van Velkinburgh JC, Zhong S, Gabriel V, Grant J, Beavis WD, Tchernev VT, Perlee L, Lejnine S, Grimwade B, Sorette M, Edgar JDM. Identification of diagnostic biomarkers for neonatal infection in premature infants. Mol Cell Proteomics. 2008;7(10):1863–75. doi: 10.1074/mcp.M800175-MCP200.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi